JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipman, J.
Right arrow Articles by Boots, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipman, J.
Right arrow Articles by Boots, R. J.
Related Collections
Right arrow Critical Care
Right arrow Complications
Right arrow Pharmacology

Anesth Analg 2003;97:1149-1154
© 2003 International Anesthesia Research Society


CRITICAL CARE AND TRAUMA

Cefepime Versus Cefpirome: The Importance of Creatinine Clearance

Jeffrey Lipman, FFA (Crit Care), FJFICM, Steven C. Wallis, PhD, and Robert J. Boots, FRACP FJFICM

Intensive Care Unit, Royal Brisbane Hospital; and Department of Anaesthesiology and Critical Care, University of Queensland, Queensland, Australia

Address correspondence and reprint requests to J. Lipman, FFA, FJFICM, Intensive Care Unit, Royal Brisbane Hospital, Herston, Qld 4029, Australia. Address e-mail to j.lipman{at}mailbox.uq.edu.au

Standard dosage recommendations for ß-lactam antibiotics can result in very low drug levels in intensive care (IC) patients without renal dysfunction. We compared the pharmacokinetics of two fourth-generation cephalosporins, cefepime and cefpirome, and examined the relationship of drug clearance (CL) to creatinine clearance (CLCR). Two separate but similar pharmacokinetic studies (which used 2 g twice daily for each antibiotic) were conducted. Blood was sampled after an initial and a subsequent antibiotic dose. Drug plasma concentrations were measured, and pharmacokinetic analyses were conducted and compared. The pharmacokinetics of cefepime and cefpirome are similar in IC patients. Any differences in drug CL can largely be attributed to differences in CLCR. Despite normal plasma creatinine concentrations, 54% of patients’ antibiotic concentrations were less than the minimum inhibitory concentration (MIC) (4 mg/L) for >20% of the dosing interval. Thirty-four percent of patients had CLCR >144 mL/min (20% higher than the expected maximum of 120 mL/min). Only CLCR was an independent predictor of antibiotic CL. Time above MIC was predicted only by CLCR. Some IC patients have a very large CLCR, which results in very low levels of studied antibiotics. Either shortening the dosage interval or using continuous infusions would prevent low levels and keep troughs above the MIC for longer periods. In view of the lack of bedside measurement of cephalosporin levels, we suggest that more frequent use be made of CLCR to allow prediction of small concentrations clinically.

IMPLICATIONS: Some intensive care patients have very large creatinine clearances that result in very low levels of fourth-generation cephalosporins. Serum levels of these antibiotics need to be maintained (time > minimum inhibitory concentration is important). Because routine measurements of cephalosporin levels are generally unavailable, we suggest that more frequent use be made of creatinine clearances to allow prediction of low levels and, hence, alterations in dosing.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. F. Roos, J. Bulitta, J. Lipman, and C. M. J. Kirkpatrick
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units
J. Antimicrob. Chemother., November 1, 2006; 58(5): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Sauermann, G. Delle-Karth, C. Marsik, I. Steiner, M. Zeitlinger, B. X. Mayer-Helm, A. Georgopoulos, M. Muller, and C. Joukhadar
Pharmacokinetics and Pharmacodynamics of Cefpirome in Subcutaneous Adipose Tissue of Septic Patients
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 650 - 655.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.